Phylogica partnered with Lions Eye Institute in October to form Vision Pharma.

Phylogica invests $15m into Vision Pharma

Biotech company Phylogica announced it had increased its shareholding in Vision Pharma to 90 per cent, following a $15 million investment using funds it had raised through a recent rights issue.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Phylogica (PYC)

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®